Results 201 to 210 of about 97,224 (305)

Prescribing Trends, Adherence, and Tolerability of Antianxiety Medications in an Indian Tertiary Care Psychiatry Outpatient Department: A Cross-Sectional Study. [PDF]

Cureus
Sejwal N, Sharma AK, Pandey D, Gupta S, Mina S.   +4 more
europepmc   +1 more source

Methylenedioxymethamphetamine (MDMA)‐related fatal poisoning in Australia, 2016 to 2025: Trends, characteristics and toxicology

Addiction, EarlyView.
Abstract Aims To determine: (1) Population rates of fatal methylenedioxymethamphetamine (MDMA)‐related poisoning over the period 2016–2023, years with high closure rates in the National Coronial Information System (NDIS); (2) the case characteristics of known cases of fatal MDMA‐related poisoning, 2016–2025; and (3) whether there have been changes in ...
Shane Darke, Johan Duflou, Agata Chrzanowska, Michael Farrell, Julia Lappin, Amy Peacock   +5 more
wiley   +1 more source

The association between chronic pain and non‐fatal overdose in people who inject drugs: Longitudinal cohort study in Montreal, Canada, 2017 to 2025

Addiction, EarlyView.
Abstract Background and aims The prevalence of chronic pain is elevated among people who inject drugs. Chronic pain may motivate drug use, potentially increasing the risk of non‐fatal overdose. We aimed to estimate the association between chronic pain and non‐fatal overdose in people who inject drugs.
Sarah Larney, Geng Zang, Harika Dasari, M. Gabrielle Pagé, Farzaneh Vakili, Adelina Artenie, Valérie Martel‐Laferrière, Nanor Minoyan, Sasha Udhesister, Julie Bruneau   +9 more
wiley   +1 more source

Managing benzodiazepine dependence arising from use of the adulterated opioid supply: a commentary. [PDF]

Subst Abuse Treat Prev Policy
Parmar G, Malette N, Ross J, Crabtree A, Bach P.   +4 more
europepmc   +1 more source

Variation in 90‐day substance use disorder‐related acute care events across United States opioid treatment programs: A Medicaid claims analysis

Addiction, EarlyView.
Abstract Background and aims Creating and tracking quality measures has improved outcomes in many areas of healthcare; however, quality measures specific to opioid treatment programs (OTPs) have not yet been developed. Based on the success seen in other fields, introducing quality measures in OTPs should help enhance positive outcomes and decrease ...
Barrett Wallace Montgomery, Tami L. Mark, Thanh Lu, William N. Dowd, Dylan DeLisle, Kathryn N. Burke, Daniel H. Barch, Gary A. Zarkin   +7 more
wiley   +1 more source

Medicine Use Preceding Fatal Poisonings Among Individuals With Bipolar Disorder. [PDF]

Basic Clin Pharmacol Toxicol
Salmelainen J, Tiihonen M, Taipale H, Lieslehto J, Tanskanen A, Tiihonen J, Hamina A.   +6 more
europepmc   +1 more source

Benzodiazepine withdrawal

The American Journal of Medicine, 1988
openaire   +2 more sources

Heroin overdose risk profiles following long‐term heroin dependence: Findings from the 18‐ to 20‐year follow‐up of the Australian treatment outcome study

Addiction, EarlyView.
Abstract Aims To identify heroin overdose and polydrug risk profiles of Australian adults with long‐term heroin dependence and assess if psychosocial, treatment, physical and mental health‐related covariates were associated with class membership. Design The 18–20‐year follow‐up of the Australian Treatment Outcome Study (ATOS). Setting Sydney, New South
Jessy S. Lim, Christina Marel, Tim Slade, Jack Wilson, Maree Teesson, Paul S. Haber, Katherine L. Mills   +6 more
wiley   +1 more source

The bidirectional predictive association between methamphetamine use and depression

Addiction, EarlyView.
Abstract Background and aims Co‐occurrence of methamphetamine dependence and depression is high, though the direction of this temporal relationship is unclear. We investigated the direction of the temporal relationship between methamphetamine use and depression.
Lucy T. Tran, Philip J. Clare, Louisa Degenhardt, Dan I. Lubman, Michael Berk, Gregory Carter, Shalini Arunogiri, Alyna Turner, Olivia M. Dean, Peter Kelly, Rebecca McKetin   +10 more
wiley   +1 more source

Predicting high‐risk novel benzodiazepines: A surveillance study of novel benzodiazepine detections and a case series of bromazolam exposures in New South Wales, Australia

Addiction, EarlyView.
Abstract Background and aims Novel benzodiazepines are increasingly detected in poisonings. Their relative toxicities remain poorly defined, complicating public health responses. Bromazolam has emerged in recent reports of severe poisoning. We sought a method to identify higher‐risk novel benzodiazepines, and to describe the clinical effects of ...
Emily Z. G. Sansoni, Janette L. Smith, Christine A. Harvey, Vanessa Shaw, Christopher Ewers, Ingrid Berling, Thanjira Jiranantakan, Jared Brown, Darren M. Roberts   +8 more
wiley   +1 more source